Stocks

The table gives an overview of all stocks, alphabetically sorted.
 Hansa Biopharma HNSA Jan 24, 2020 72.50 +2.33   
 HANZA Holding HANZA Jan 24, 2020 17.95 +1.13   
 Havsfrun Investment HAVS Jan 24, 2020 18.80 -3.09   
 Havsfrun Investment B HAVB Jan 24, 2020 18.80 -3.09   
 Havyard Group HYARDO Jan 24, 2020 3.05 0.00   
 Heba B HEBAB Jan 24, 2020 89.80 +2.98   
 Hedera Group HEGR Jan 24, 2020 7.90 +3.95   
 Heimstaden Pref HEIMPREF Jan 24, 2020 385.00 -0.26   
 Heliospectra HELIO Jan 24, 2020 6.08 +1.50   
 Hemcheck Sweden HEMC Jan 24, 2020 6.16 +2.33   
 Hemfosa Fastigheter HEMF Jan 24, 2020 125.40 +0.32   
 Hemfosa Fastigheter Pref HEMFPREF Jan 24, 2020 199.50 +0.25   
 Herantis Pharma HRNTS Jan 24, 2020 75.00 0.00   
 Hexagon B HEXAB Jan 24, 2020 560.40 +2.71   
 Hexagon Composites HEXO Jan 24, 2020 33.35 -7.62   
 Hexatronic Group HTRO Jan 24, 2020 60.50 -0.82   
 Hexpol B HPOLB Jan 24, 2020 91.60 +2.35   
 Hiddn Solutions HIDDNO Jan 24, 2020 1.73 +2.98   
 Hifab B HIFAB Jan 24, 2020 2.40 +2.56   
 HiQ International HIQ Jan 24, 2020 53.40 +1.91   
 HMS Networks HMS Jan 24, 2020 178.40 -0.34   
 Hofseth BioCare HBCO Jan 24, 2020 9.60 0.00   
 Hoist Finance HOFI Jan 24, 2020 48.70 +1.46   
 Holmen A HOLMA Jan 24, 2020 282.00 +1.08   
 Holmen B HOLMB Jan 24, 2020 273.20 +0.81   
 HomeMaid B HOMEB Jan 24, 2020 6.04 -3.21   
 Hoodin HOODIN Jan 24, 2020 10.30 -5.50   
 Hoylu HOYLU Jan 24, 2020 3.34 +1.06   
 Hufvudstaden A HUFVA Jan 24, 2020 192.50 +1.64   
 Hufvudstaden C HUFVC Jan 24, 2020 4 540.00 0.00   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK